A 72-year-old man with persistent atrial fibrillation, a history of myocardial infarction and transient ischemic attack, and a CHADS 2 -VASc score of 3 on warfarin underwent an elective atrial fibrillation ablation. His international normalized ratio was 2.1 on the day of the procedure; he had taken his last warfarin dose 2 days before the procedure. The ablation was performed under general anesthesia, and an uncomplicated preprocedural transesophageal echocardiogram (TEE) was performed that excluded left atrial thrombus. The TEE probe was placed within the esophagus for the duration of the procedure, in part to guide the transseptal puncture. Wide-area circumferential ablation was performed to isolate the pulmonary veins, with further ablation of complex fractional atrial electrograms. Intravenous heparin was given during the procedure to maintain his activated clotting >300 seconds, and protamine was administered to reverse anticoagulation before removal of the sheaths at the end of the procedure.
Seventeen hours after the procedure, the patient had 100 mL fresh hematemesis, developed melena, and complained of dysphagia. His hemoglobin had dropped by 2 U compared with the beginning of the procedure (166 to 144 g/L). The rest of the blood results were as follows: sodium, 148 mmol/L; potassium, 4.0 mmol/L; urea, 7.4 mmol/L; and creatinine, 114 mmol/L. An urgent computed tomography of the thorax with contrast was requested that showed the distal two thirds of the esophagus expanded with low-attenuation material, with contrast seen adjacently in a tightly compressed lumen. There was no layering of contrast to suggest active bleeding (Figures 1, 2A, and 3A). A diagnosis of intramural hematoma of the distal two thirds of the esophagus was made. A chest radiograph was obtained for completion that showed subtle signs pointing toward the diagnosis (Figure 4 ). The patient remained hemodynamically stable and did not require transfusion or surgical intervention. The case was discussed with a cardiothoracic surgeon and a gastroenterologist and was managed conservatively by keeping the patient nil-by-mouth for 24 hours, with gradual introduction of liquid followed by soft food. Warfarin was stopped for 3 days, and the patient was then discharged when able to tolerate normal diet. His international normalized ratio at discharge was 1.2, and his hemoglobin was 124 g/L. He was also prescribed metronidazole and cefuroxime prophylactically for 7 days. The patient was followed up at his local hospital the day after discharge and restarted on warfarin without low-molecular-weight heparin bridging therapy. Three weeks after the first computed tomography scan, the patient had a follow-up computed tomography at his local hospital that showed complete resolution of esophageal hematoma ( Figures 2B and 3B) .
Esophageal injury is a recognized complication of radiofrequency ablation-related procedures, 1 but only 5 cases of esophageal hematoma caused by TEE during atrial fibrillation ablation are described in the literature.
1-3 Kumar et al 1 described an incidence of 0.27% (3 of 1110 patients) of TEE-related esophageal hematoma after atrial fibrillation ablation. Although this is an extremely rare complication, it is important to recognize signs and symptoms such as odynophagia, dysphagia, chest pain, hematemesis, and melena early. These symptoms will often present early (within 12 hours 1-3 ) with TEE-related esophageal injury, as in our case report. A much more delayed presentation is seen (1-4 weeks 4-6 ) with atrioesophageal fistula caused by radiofrequency catheter ablation, and consequences are often fatal. Therefore, it is likely that the esophageal hematoma in this case report was a result of direct trauma from the TEE, although we accept that, given the rare nature of this complication and the inability to study it more carefully with gross pathology or histology, it is not possible to be certain of the exact mechanism of injury.
Diagnostic investigations should include computed tomography imaging of the thorax in the first instance to rule out atrioesophageal fistula before endoscopy. Endoscopy or barium swallow studies may be useful in assessing structural and functional damage caused by the esophageal hematoma and for follow-up monitoring. 1 Unless the patient becomes hemodynamically unstable, esophageal hematoma can usually be managed conservatively by keeping the patient nil-by-mouth initially, followed by careful reintroduction of fluids and then a soft
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November 10, 2015 diet. A multidisciplinary approach in managing the hematoma is important to allow appropriately guided reintroduction of anticoagulation, and it is probably advisable that low-molecular-weight heparin be omitted when warfarin is restarted. 1 Close monitoring of the international normalized ratio to reach a therapeutic range when anticoagulation is restarted is recommended to reduce the risk of rebleeding or thrombosis.
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